Comparison between Indo US Bio-Tech IPO and Mahickra Chemicals IPO.
Indo US Bio-Tech IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Mahickra Chemicals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Indo US Bio-Tech IPO is up to ₹6.92 Cr whereas the issue size of the Mahickra Chemicals IPO is up to ₹4.98 Cr. The final issue price of Indo US Bio-Tech IPO is ₹51.00 per share and of Mahickra Chemicals IPO is ₹25.00 per share.
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹24.00 per share | |
| Issue Price (Upper) | ₹25.00 per share | |
| Issue Price (Final) | ₹51.00 per share | ₹25.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 6000 shares |
| Fresh Issue Size | 13,56,000 shares | 19,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.92 Cr | up to ₹4.98 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,56,000 shares | 19,92,000 shares |
| Issue Size Total (Amount) | up to ₹6.92 Cr | up to ₹4.98 Cr |
Indo US Bio-Tech IPO opens on Apr 30, 2018, while Mahickra Chemicals IPO opens on Apr 16, 2018. The closing date of Indo US Bio-Tech IPO and Mahickra Chemicals IPO is May 03, 2018, and Apr 18, 2018, respectively.
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 30, 2018 | Apr 16, 2018 |
| Issue Close | May 03, 2018 | Apr 18, 2018 |
| Basis Of Allotment (Tentative) | Apr 23, 2018 | |
| Initiation of Refunds (Tentative) | Apr 24, 2018 | |
| Credit of Share (Tentative) | Apr 25, 2018 | |
| Listing date (Tentative) | May 11, 2018 | Apr 26, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indo US Bio-Tech IPO P/E ratio is , as compared to Mahickra Chemicals IPO P/E ratio of .
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹24.76 Cr. | ₹18.09 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Indo US Bio-Tech IPO Retail Individual Investors (RII) are offered 6,78,000 shares while in Mahickra Chemicals IPO retail investors are offered 6,78,000 shares. Qualified Institutional Buyers (QIB) are offered in Indo US Bio-Tech IPO and in Mahickra Chemicals IPO.
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 74,000 shares | 1,08,000 shares |
| QIB | ||
| NII | 6,78,000 shares | 9,96,000 shares |
| RII | 6,78,000 shares | 9,96,000 shares |
| Employee | ||
| Others | ||
| Total | 13,56,000 shares | 19,92,000 shares |
Indo US Bio-Tech IPO subscribed 19.69x in total, whereas Mahickra Chemicals IPO subscribed 27.85x.
| Indo US Bio-Tech IPO | Mahickra Chemicals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 19.52x | 22.42x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.87x | 33.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 19.69x | 27.85x |
